These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18192778)

  • 41. Update from CROI 2008 on approved HIV drugs.
    Dalton P
    Proj Inf Perspect; 2008 Apr; (45):9-17. PubMed ID: 19248293
    [No Abstract]   [Full Text] [Related]  

  • 42. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 43. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
    Koyalta D; Charpentier C; Beassamda J; Rey E; Si-Mohamed A; Djemadji-Oudjeil N; Bélec L
    Clin Infect Dis; 2009 Jul; 49(1):155-9. PubMed ID: 19480574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 45. Similar challenges with retention in care issues.
    Krentz HB; Siemieniuk RA; Gill MJ
    Clin Infect Dis; 2007 Dec; 45(11):1527. PubMed ID: 17990241
    [No Abstract]   [Full Text] [Related]  

  • 46. Durability of clinical responses to anti-HIV therapies.
    Laurence J
    AIDS Read; 2008 Mar; 18(3):120-1. PubMed ID: 18398977
    [No Abstract]   [Full Text] [Related]  

  • 47. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Travel medicine and HIV infection.
    Igreja R
    Int J STD AIDS; 2008 Sep; 19(9):577-80. PubMed ID: 18725545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regression of HIV-associated mucosa-associated lymphoid tissue lymphoma during highly active anti-retroviral therapy.
    Ishimaru F
    Clin Infect Dis; 2008 Apr; 46(7):1124. PubMed ID: 18444837
    [No Abstract]   [Full Text] [Related]  

  • 50. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 51. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
    Lagnese M; Daar ES
    Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV remains a deadly disease.
    Lundgren JD
    HIV Med; 2004 Jul; 5(4):251-2. PubMed ID: 15236612
    [No Abstract]   [Full Text] [Related]  

  • 54. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Necrotizing epiglottitis in an infant: an unusual first presentation of human immunodeficiency virus infection.
    Tebruegge M; Connell T; Kong K; Marks M; Curtis N
    Pediatr Infect Dis J; 2009 Feb; 28(2):164-6. PubMed ID: 19106777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):56-8. PubMed ID: 19280746
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Diaz-Linares M; Vázquez E
    Posit Aware; 2008; 19(1):50-2. PubMed ID: 18546578
    [No Abstract]   [Full Text] [Related]  

  • 58. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).
    Avettand-Fènoël V; Chaix ML; Blanche S; Burgard M; Floch C; Toure K; Allemon MC; Warszawski J; Rouzioux C;
    J Med Virol; 2009 Feb; 81(2):217-23. PubMed ID: 19107966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
    Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
    J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.